- Research Grants
I am graduated in Dentistry and Pharmaceutical Sciences, both at the University of São Paulo (Brazil) and MSc degree in Pharmacology, Medical School of Ribeirão Preto-USP. I am currently on the PhD in Pharmacology, Medical School of Ribeirão Preto-USP. (Source: Lattes Curriculum)
|News published in Agência FAPESP Newsletter about the researcher|
|Research suggests cannabidiol can reduce symptoms of depression|
Ketamine has been widely studied as a drug with rapid and effective antidepressant action in resistant patients to the available conventional treatments. Recently, we have demonstrated that Cannabidiol (CBD), as well as ketamine, has a rapid and sustained antidepressive effect in different animal models. However, the mechanisms involved in this effect are not yet known. It has been assi...
Introduction: Epigenetic mechanisms, such as DNA methylation (is regulated by DNMTs), are thought to play an important role in the neurobiology of depression. In this sense, we demonstrated that inhibitors DNA methylation have antidepressant-like effect in animals submitted to forced swimming test and tail suspension. Objectives: Whereas DNMTs inhibitors have different mechanism of acti...
Recent evidences have suggested that nitric oxide (NO) might be involved on the neurobiology of depression, since the its synthesis inhibition induces antidepressant-like effects in animal models. The participation of specific brain regions and the molecular mechanisms involved in such effects remain to be investigated. Considering that intra-hippocampal injection of a preferential inhi...
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
|Data from Web of Science|